Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Apollomics Vebreltinib Gets FDA Orphan Drug Status for Lung Cancer Subtype
Maxpro Capital Acquisition Extends It Deadline to Complete Business Combination
Maxpro Capital Acquisition (NASDAQ:JMAC) has announced that its sponsor, MP One Investment, has requested to extend the date by which the Co. has to consummate a business combination from Oct. 13, 202
Loading...
No Stock Yet